Download Market Wire News App

JAZZ

Quote

Short

News

Articles

Message Board

Jazz Pharmaceuticals plc (NASDAQ : JAZZ ) News

News Releases

JAZZ News Releases

July 09, 2026 11:15:23 am

IBN Spotlights

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Sets New 52-Week High in Thursday Session

June 26, 2026 09:22:31 am

SeekingAlpha

Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)

June 23, 2026 03:00:00 pm

Motley Fool

Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks

June 17, 2026 07:47:29 am

SeekingAlpha

Jazz, AbCellera in deal to develop T-cell engaging multispecific antibodies

June 17, 2026 07:00:00 am

PR Newswire

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies

June 16, 2026 04:05:00 pm

PR Newswire

Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia

June 12, 2026 08:30:36 am

SeekingAlpha

Jazz Pharma announces late-stage trial setback for lung cancer therapy

June 12, 2026 08:00:00 am

PR Newswire

Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer

June 08, 2026 10:59:18 am

SeekingAlpha

These healthcare stocks have maintained Strong Buy ratings for months

June 04, 2026 07:45:00 am

PR Newswire

Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account